chrisvoncsefalvay/vaers-outcomes huggingface dataset:
another swollen lymph node an inch and a half higher from her collarbone; lymph nodes on the same side of her injection (left collarbone); This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of LYMPHOEDEMA (lymph nodes on the same side of her injection (left collarbone)) and LYMPHADENOPATHY (another swollen lymph node an inch and a half higher from her collarbone) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 027B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced LYMPHOEDEMA (lymph nodes on the same side of her injection (left collarbone)). On 15-Mar-2021, the patient experienced LYMPHADENOPATHY (another swollen lymph node an inch and a half higher from her collarbone). On 21-May-2021, LYMPHADENOPATHY (another swollen lymph node an inch and a half higher from her collarbone) had resolved. At the time of the report, LYMPHOEDEMA (lymph nodes on the same side of her injection (left collarbone)) outcome was unknown. Not Provided          Lymph nodes were on the same side of the injection site and they were swollen an inch and a half higher than the collarbone. Patient visited her physician for consultation and was advised to wait 6-8 weeks for the symptoms to go away. Lymph nodes returned back to normal in 4-5 weeks after the second vaccine.  No concomitant medication were reported.  No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: second dose info added, event outcome updated.
Systemic: red raised rash appearing minutes after injection and still present-Mild, Additional Details: Patient states her boyfriend noticed the rash within minutes of injection.  small raised red bumps on chest extending just below collar bone and on back of neck extending to the shoulder blades.  not itchy
The typical sore arm; puffy around my eyes/little puffy under his eyes; sensation around his eyes/felt a sensation on the side of his eyes; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received his first dose of bnt162b2 (BNT162B2 reported PFIZER-BIONTECH COVID-19 VACCINE; unknown lot number and expiration date), via an unspecified route of administration on Jan2021 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient inquired if his symptoms after the first dose of the vaccine are normal, was this a reaction to the vaccine and if he should get the second dose. He mentioned that he got the first dose of the covid vaccine earlier this week (Jan2021) and he had "the typical sore arm" but went on to report that about 3 hours afterward, he felt a sensation on the side of his eyes and below them so he asked his wife, "am I puffy around my eyes". He had no severe reaction or anything like that. He had no shortness of breath or rapid heartbeat or anything. He did not have any of those issues at all. Like any other shot, he had a sore arm. Then about 3 hours after he got it, he noticed a sensation around his eyes that last for about 20 minutes. He thought it had something to do with vaccine. His wife said he looked a little puffy under his eyes. He knows there is a "glad" under the eye area. He reported that he looked at the common side effects but didn't see his reaction so he doesn't know if he should be concerned. In the instructions for the vaccine it said there could be an issue with skin mucosa, but he had no swelling of the lips, throat, face, or anything. He wants the second dose. Obviously if someone had a severe reaction, they would not get the second shot. He inquired if he should be concerned about or not, if this is a side effect. The outcome of the events was unknown.  The following information on the batch/lot number has been requested.
This spontaneous report as received from a 60 years old female consumer with codeine allergy and no pertinent medical history. The patient was vaccinated with 1 dose of ZOSTAVAX (route and lot # not reported) on 05-OCT-2012. Concomitant medications included hydrochlorothiazide (+) losartan potassium, rifabutin, LEXAPRO and trazodone hydrochloride. The patient stated that after she had gotten the ZOSTAVAX, she got a cold sore on her lip, on 07-OCT-2012. In addition, the patient was still itchy at the injection site of her arm. The patient sought medical attention by a doctor visit. No lab diagnostic/studies were performed. The patient was given cold sore medicine and valacyclovir for the events. The outcome of cold sore on her lip was reported as recovering. The relationship for the events and ZOSTAVAX was not reported. Additional information has been requested.
pt reported to MD had nickle-size blister on the lt arm where flu vax was administered; MD reported to clinc that pt had lemon size redness & swelling in the same area; also reported 1/4"-1/2" hole in this area;
4 inch palpable mass that she describes as being "fluid filled," below the site of injection; slight tenderness right at the injection site; This spontaneous report was received from a pharmacist and refers to a female patient of an unknown age. The patient's historical vaccines included an unspecified flu shot, unspecified shingles vaccine, administered twice and pneumococcal 13v conj vaccine (PREVNAR 13) with no adverse reactions after their administration. The patient's historical drugs included sulfanilamide (SULFA). The patient's concurrent conditions included allergy to sulfanilamide (SULFA). o information regarding the patient's concomitant medications was provided. On 14-JAN-2021, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), 0.5 milliliter, intramuscularly in the left deltoid (lot # and expiration date were unknown) for prevention of pneumococcal disease. On 14-JAN-2021, the patient developed 4 inch palpable mass fluid filled below the site of injection and a slight tenderness right at the injection site, that she reported via telephone call to the administering pharmacist seeking for medical attention. The patient did not receive any treatment. The outcome of all events was reported as recovering.  The casual relationship between the events and the suspect vaccine was not reported.
Slept for 3 days straight. Followed by severe fatigue an was only able to stay awake for up  to 2 hours a day. Treatment was Vitamin D 50,000IU per week. Gradually resolving to this day still (present). Severe muscle weakness, especially in the face. Gradually progressed to other areas of my body, including my feet. Weakness has lessened but continues intermittently, especially when tired. No treatment. Currently have problems in forearms and legs falling asleep on me (numbness and tingling sensation). Happens during inactivity approximately every other day.  Self massage and I move it around. Getting nodules on finger/hand joints with fluid collecting under the skin. Pain in my toes. Still affecting to the present time. No treatment. Neurological- very poor balance, considerable loss of short term memory, difficulty with focus and concentration,
Approximately 10 minutes after injection, a dime-sized raised area appeared to the right of the injection site (on the left leg); slight redness around the raised area seen.
VACCINE UNKNOWN WHAT WAS GIVEN, WAS NOT WRITTEN DOWN, CAN NOT REACH PATIENT
I had gone on vacation and had been on a long flight. My husband ended up in the hospital and I was there with him. A day or two later I had a runny nose, sinus drainage, congestion, and cough. I was tired but thought that may be because of the trip. My daughter had a COVID-19 Home Test and I took that I was positive. I took a baby Aspirin and about four days in I was doing better. The symptoms were really only like a mild cold.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Physician).  A 65-year-old male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "DM" (unspecified if ongoing); "HTN" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: Treatment of COVID-19; (unspecified date) Negative, notes: Rebound symptoms after testing negative ; (Jun2022) Positive, notes: Testing positive again. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical information: Reporter type: Healthcare Professional reporting for a patient. No known allergies were reported. Antiviral treatment was given to the patient via oral route of administration for treatment of COVID-19. No Other medications in 2 weeks were reported.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: The reported COVID-19 positive after COVID-19 immunization is considered ineffective of BNT162B2, and the Company cannot completely exclude the possible causality between the reported events and BNT162B2 administration.
severe flu type symptoms; severe upper respiratory infection; Initial information received on 17-Nov-2020 regarding an unsolicited valid non-serious social media case received from a consumer (patient) via social media.  This case involves a patient (with unknown demographics) who experienced severe flu type symptoms (influenza like illness) and severe upper respiratory infection (upper respiratory tract infection), while he/she received INFLUENZA VACCINE.  The patient's past medical treatment(s), vaccination(s) and family history were not provided.  It was reported that patient had never been sicker and may be allergic to flu shot.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number and expiry date not reported via an unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed severe flu type symptoms (influenza like illness) and severe upper respiratory infection (upper respiratory tract infection) (unknown latency) following the administration of INFLUENZA VACCINE.  Other relevant tests not reported.  It was not reported if the patient received a corrective treatment.  At the time of reporting, outcome was unknown for the events.  There will be no information on the batch number for this case.
Dizzy spell; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy spell) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced DIZZINESS (Dizzy spell). On 02-Mar-2021, DIZZINESS (Dizzy spell) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  The patient had a dizzy spell that lasted for a few minutes.  No treatment information was provided.
Leg became very hot to the touch, red, inflamed immediately upon vaccination.  Vaccination site remained hot to the touch from 3/29-4/2 (approximately 5 days).  Rash at injection site appeared on 3/30, full body rash appeared on 3/31.  Runny nose appeared on 4/5-4/12, and a full body rash began at her hair line then spread through her body (torso, back, arms, legs) on 4/12.  She has a body rash still on 4/15, and has not had a fever since 3/27.
COVID -19 symptoms started on October 25 and at that point I had a headache and fatigue. On the 27th I had a runny nose, and I went and got tested on October 28th and it was positive. Symptoms lasted for about 8 days, and I still have a dull headache.
shingles; This spontaneous report has been received from a lawyer regarding a case in litigation, concerning a female patient of unknown age. Her medical history, concurrent conditions and concomitant medications were not reported. In 2013, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, lot #, expiration date, dosage, anatomical location and route of administration were not reported), as prescribed and/or administered by a pharmacist at a pharmacy, for the long-term prevention of shingles and/or zoster-related conditions. Subsequent to vaccination, she was treated by a healthcare provider for shingles (herpes zoster). As a direct and proximate result of zoster vaccine live (ZOSTAVAX) use, the patient had and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for those injuries; significant medical and related expenses as a result of those injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome for herpes zoster was considered to be not recovered.
I have a severe rash on my cheeks and around my eyes that burns and is very itchy.  I saw my doctor via a tele-med appointment and she prescribed methylPREDNISolone 4 MG tablets.  The rash is clearing up but it is still very red at times.  In addition I have a rash on my left ankle similar to a jelly fish sting in that it is around the lower portion of my ankle.  It hurts to touch it and is very warm to the touch and is also itchy.  I also had trouble using my leg until I was using the steroids were in my body for 2 days.
From shoulder (injection site) right elbow -> red, swollen, hot to touch with low grade fever -> taking TYLENOL and ice pack.
Extreme erythema & increased temperature & palpitation to whole upper right arm where injection given -aches, sore
Patient came in for covid 19 vaccine. When administering the vaccine the serum leaked out the syringe at the needle attachment. The patient was given a full second dose and instructed to stay in facility for 30 minutes.
Temperature Excursion Product Administered; Initial Report Received on 07-DEC-2022  This is a spontaneous report, received from a registered nurse regarding a female patient, aged 42 years, who received HEPLISAV-B for hepatitis B immunisation.   Medical history at the time of vaccination was reported as shrimp allergy.  Concomitant medications were not reported.  On 07-NOV-2022, a dose of HEPLISAV B (Lot #937783, expiration date 29-SEP-2023, NDC #43528-003-05), route and site not specified, was administered for hepatitis B immunisation.    On 25-NOV-2022, 16 days after the patient was vaccinated with HEPLISAV B, the reporter received notice that the HEPLISAV B that the patient received underwent a temperature excursion.  Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
SUSPECTED MYOCARDITIS; This spontaneous report was received from literature.  This report concerned a patient of unspecified age, sex, race and ethnicity. The objective of this study was to understand clinical course and short-term outcomes of suspected myocarditis after the coronavirus disease 2019 (COVID-19) vaccination has important public health implications in the decision to vaccinate youth. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN,expiry: unknown) dose, 1 total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced suspected myocarditis. Laboratory data (dates unspecified) included: ECG (NR: not provided) was abnormal, and Troponin (NR: not provided) elevated. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of suspected myocarditis was not reported. The authors emphasized that case series demonstrates that myocarditis temporally related to COVID-19 vaccination is characterized by a mild illness with rapid resolution of symptoms in most patients. However, longer-term outcome data are lacking. We emphasize the importance of reporting suspected myocarditis cases after COVID-19 vaccination to the Vaccine Adverse Events Reporting System or similar reporting systems for patients in other countries to better define the characteristics of this syndrome and its relationship to the receipt of COVID-19 vaccines. Future studies that focus on determining risk factors and mechanisms of development of myocarditis are urgently needed, in particular, as COVID-19 vaccines become more widely available to younger children in the future.  This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20220314046-COVID-19 VACCINE AD26.COV2.S-Suspected myocarditis. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.
Baby got one year vaccines. Father said that baby developed high fever 10/15/18 and then on 10/16/18 and 10/17/18, baby developed rash all over. I saw the pt on 10/19/18, baby has pustules, vesicles and papules in various stages both legs, arms, neck, trunk, back, palms and soles. Baby is afebrile now, father denies cough, URI. No other complaints. Baby is happy and playful. Blood work attempted but pt has lot of pustules on arms so was unsuccessful.
Aside from fever and fatigue and stomach bloating, my blood pressure went higher and my pulse was fast.  I messaged my doctors.  I was going to have my heart monitored, but due to a non Covid death in the family, I had to postpone.  I have been using a MCOT since 12/10/2021.  I am still having palpitations.
This spontaneous report as received from a pharmacy technician concerning a currently 42 year old patient. Gender was not reported. Medical history and concurrent conditions were not reported. On 24-APR-2014, the patient was vaccinated with VARIVAX lot#J003700; expiration date: 27-MAR2015, (dose, strength and route were not reported). Secondary and concomitant therapies were not reported. Patient was vaccinated with VARIVAX that was exposed to 43.1 degrees F  for 29 hours on 03-MAR-2014. This is one of several reports from the same reporter. Additional information has been requested.
BURNING PAIN IN LEFT ARMPIT (SAME ARM AS INJECTION). FELT LIKE SWOLLEN AXILLARY LYMPH NODES. LASTED FOR 1 WEEK AND STILL HAS SLIGHT PAIN WHEN I OVER EXTEND MY ARM  BY STRETCHING IT OUT BUT PAIN IS MORE BEARABLE.
got very cold; Fever; This is a spontaneous report from a contactable consumer. A male patient (Reporter's husband) of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced got very cold, fever. Reported that her husband had a fever but decided to go out and mow the grass. He's a marine and he just works it out. The outcomes of events were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
4 cm x 3 cm eryth. are with hard area beneath area warm to touch
Nausea, severe muscle and joint paint, difficulty walking, fever, chills, lasting for approximately 8 days - 5 severe
Shingles appeared the following day after vaccination were give. Patient has been very unco and in pain from shingles. Received valacyclovir 1 Gram 3xdaily, without relief and now on acyclovir 5% oint Prednisone, and Gabapentin.
Tested positive for COVID; Tested positive for COVID; Phlegm in throat; Cough; Runny nose; cold; Sneezing; Body aches; Nausea; Chills; Headache; This is a spontaneous report from a contactable consumer (patient). A 51-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 29Dec2020 14:50 at single dose at right arm for covid-19 immunization. No additional vaccines administered on the same date. Patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Medical history included ongoing migraine. Concomitant medication included acetylsalicylic acid, caffeine, paracetamol (EXCEDRIN EXTRA STRENGTH) for migraine, patient had been alternating this with paracetamol (TYLENOL) while she has been recovering. She clarified the symptoms she experienced as the same day she got the vaccine that evening she had a headache on 29Dec2020. It eventually became a migraine and she left work early. On 30Dec2020 she had body aches, little nausea, and chills. On 31Dec2020, she had more chills, a runny nose, she felt like she was coming down with a cold. She was sneezing, had more chills, more body aches. On 01Jan2021 she felt like she noticed she had phlegm in her throat, but she did not have any pain. The phlegm was causing her to cough more. She had a runny nose the next morning as well. She did the rapid test for COVID on 02Jan2021 evening, and it was positive. She had a headache almost every day. The body aches had pretty much worn off. Runny nose and sneezing resolved in Jan2021. Phlegm in throat confirmed with no pain. This also resolved, as well as coughing. Outcome of event tested positive for COVID was unknown, outcome of event headache was not recovered. outcome of event nausea was recovered on 07Jan2021, event chills was recovered on 08Jan2021, outcome of other events was recovered on unspecified date in Jan2021. The adverse events resulted in neither doctor or other healthcare professional office/clinic visit, nor emergency room/department or urgent care.  Information of lot/batch number has been requested.
April 17, 2021 developed severe hip pain, unable to stand for any period of time. April 18th severe lower back pain, can't stand up strait, bent over at waist got progressively worse. Went to orthopedic  4-19-21 who administered a shot of cortisone to left hip area, extreme pain continued went back to orthopedic on 4-22-19 cortisone shot lower left back area, No relief. Visited chriopractor every weekday till present for adjustments, Have had some relief but still have pain mostly in left hip thigh area. Unable to sit or stand for any period of time the only relief is when I lay down.